Janux Therapeutics, Inc. JANX
JANX
Janux Therapeutics, Inc. INBX
Inhibrx Biosciences, Inc. MLYS
Mineralys Therapeutics, Inc. CLYM
Climb Bio, Inc. ANEB
Anebulo Pharmaceuticals, Inc. JBIO
Jade Biosciences, Inc. IPSC
Century Therapeutics, Inc. GLUE
Monte Rosa Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. DAWN
Day One Biopharmaceuticals, Inc.
Janux Therapeutics, Inc. INBX
Inhibrx Biosciences, Inc. MLYS
Mineralys Therapeutics, Inc. CLYM
Climb Bio, Inc. ANEB
Anebulo Pharmaceuticals, Inc. JBIO
Jade Biosciences, Inc. IPSC
Century Therapeutics, Inc. GLUE
Monte Rosa Therapeutics, Inc. EWTX
Edgewise Therapeutics, Inc. DAWN
Day One Biopharmaceuticals, Inc.
Performance
| Periode | JANX | INBX | MLYS | CLYM | ANEB | JBIO | IPSC | GLUE | EWTX | DAWN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -9.48 % | 190.27 % | 224.22 % | 52.81 % | 137.76 % | -90.36 % | 15.40 % | 136.87 % | 31.63 % | 1.69 % |
| YTD | -51.03 % | 120.98 % | 254.65 % | -5.51 % | 46.75 % | -90.45 % | -46.74 % | 40.59 % | -44.39 % | -43.04 % |
| 1Y | -47.17 % | 117.42 % | 219.68 % | -64.04 % | 26.70 % | -88.02 % | -62.57 % | 103.17 % | -52.76 % | -49.37 % |
| 3Y | 93.11 % | 1.78 % | 135.60 % | -75.02 % | -15.69 % | -98.64 % | -94.56 % | 27.18 % | 40.62 % | -64.77 % |
| 5Y | 3.66 % | 78.31 % | 135.60 % | -75.02 % | -67.34 % | -98.88 % | -97.57 % | -52.80 % | -49.89 % | -69.19 % |
| 10Y | 3.66 % | 63.35 % | 135.60 % | -75.02 % | -67.34 % | -98.88 % | -97.57 % | -52.80 % | -49.89 % | -69.19 % |
| Depuis le début | 3.66 % | 63.35 % | 135.60 % | -75.02 % | -67.34 % | -98.88 % | -97.57 % | -52.80 % | -49.89 % | -69.19 % |